Severe thrombotic thrombocytopenic purpura OH'P) requiring intervention is a serious complication following bone marrow transplant (BMT). The therapeutic modalities (unlike classic TIP) are limited since therapeutic plasma exchange has a very poor response. BMT TTP is usually associated with cyclosporine, total body irradiation or other medications. A total of 10 patients who underwent BNIT were diagnosed with severe TTP during 1996-2001 age range 5-58 (mean 27.2). The diagnosis was made based on the criteria of thrombocytopenia, microhemangiopathic hemolytic anemia, elevated LDH mean 5012 (range 4672-9232) and schistocytes on the peripheral smear. Of the 10 patients, 2 were treated with plasma exchange (20%), and 9 patients were treated with supportive care and the discontinuation of cyclosporine (90%). Of the 10 patients 9 were allogeneic bone marrow transplants 5 being MUD (50%) all patients except i were receiving cyclosporine at the time of diagnosis. Outcome: mortality was 100% in all patients treated with and without plasma exchange. There appears to be no benefit of plasma exchange in patients with severe TTP after BMT and an improved understanding of the pathogens is and treatment of this complication is currently needed. Sto~wls, R. V~I; Gree~z, P.D/; Chao, N.J/; Smitt, , C, 4.2; Nikcevieh, D.AJ 1. Departmem of Medicim, Dzdee U~tiversity 3ledical Cemer, Din'ham, , NC; 2. Moffitt Cmzcer Cemer, Tampa, FL. Natural killer (NK) cells are increasing important within the context of cellular therapies, to include allogeneic bone marrow transplantafion and donor lymphocyte infilsions. Historically, 51Cr release has been the standard hz vitro measurement for NK activity. However, qCr release has pour sensitivity for NK activity if effector cell numbers are limiting and patients undergoing allogeneic transplantation frequently have very low blood cell counts. To support our ongoing clinical protocols in allogeneic bone marrow transplantation, we have developed a fluorescence-based assay to monitor NIL function that is accurate even with limiting effector cell numbers. In this assay the target cells are labeled with carbo .xyfluorescein diaeetate succinimydyl ester (CFSE). After incubations with NK cells, the kilting of target cells is monitored by their membrane permeability as detected with the nucleic acid stain 7-amino actinomycin D (TAAD). In parallel assays, the CFSE-based assay generated dose-response curves similar to those achieved with SlCr release assays. However, the fluorescence-based assay remained sensitive at lower target cell numbers where the results of 51Cr-release assays were not interpretable. As would be anticipated, an immtmomagnetic selection of CD56 + ceils greatly increased the sensitivity of the assay. More importantly, with CD56+-selected ceils as effectors the CFSE-based lysis assay yields classic sig~oidal dose-response curves in assays performed in as little as one hour. Finally, we note that with this combination of fluorescent dyes file samples can be fixed with formaldehyde and processed at a later time. Taken together, these data demonstrate this fluorescence-based lysis assay is sensitive, easy to conduct and time effective, yet the materials are inexpensive, making it suitable for clinical use. As increasing numbers of unrelated donor stem cell transplants utilize peripheral blood stem cells (PBSC), physicians are performing fewer marrow collections. The National Marrow Donor Program (NMDP) evaluated data from its collection centers to determine if there were differences in marrow cellularity or donor morbidity based on the marrow collection experience of the collection center. NMDP collection centers (n=97) were divided into tbur groups, based on the nmnber of NMDP marrow collections performed at the center in 2001. Each group performed appro~ mately 25% of all NMDP marrow collections (n=926) in 2001. Group 1 centers each performed _>24 NMDP collections, group 2 between 16 and 23, group 3 between 8 and 15 collections, and group 4 performed <7 collections in 2001. The median cell dose (x 10S/kg recipient weight) and median nucleated ceil concentration (x 106/ml) were compared among groups using a median test. There was no significant difference in the median cell dose among the four groups of centers, however there was a borderline significant difference (P-value = 0.02) among median cell concentrations, where group 2 had a slightly higher median cell concentration than the other groups. The incidence of severe (very intense, prolonged or excruciating) donor post-donation complication rates reported by NMDP donor centers was also compared. There were no significant differences among groups 1, 2, 3 and 4 at 0.5%, 1%, 2% and 2% respectively. In conclusion, NMDP data do not appear to indicate that collection centers with less marrow collection experience produce less cellular products or result in increased donor morbidity. Our previous research indicated that feelings of ambivalence or reluctance about donation were associated with donors' decisions not to donate, and with less positive physical and psychosocial outcomes among donors who donated despite feeling ambivalent. The current study examines the prevalence of ambivalence among newly recruited potential bone marrow donors, and identifies factors associated with greater ambivalence. Using a cross-sectional design, questionnaires were mailed to a stratified random sample of individuals newly recruited to the NMDP registry at 71 local donor centers. 426 (63%) of new recruits completed and returned the questionnaire. Bivariate analyses indicated that multiple recruimmnt experience and donor perception variables were significantly associated with ambivalence. Multivariate analysis revealed that eight variables --participating in other volunteer activities (p<.05), joining at a drive for a specific patient (p<.05), perceiving the recruitment staff as less informative (p<.001), being BB&MT 85
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